Table 5.
SSRI | 5HT antagonist | |||||
---|---|---|---|---|---|---|
Muscle | Pre | Post | p value | Pre | Post | p value |
Rectus femoris | 0.90±0.37 | 0.87±0.27 | 0.89 | 0.97±0.21 | 1.1±0.20 | 0.18 |
Vastus lateralis | 0.74±0.29 | 0.75±0.22 | 0.92 | 0.90±0.29 | 0.92±0.25 | 0.21 |
Medial hamstring | 0.51±0.33 | 0.54±0.3 | 0.89 | 0.37±0.12 | 0.38±0.13 | 0.75 |
Medial gastrocnemius | 0.37±0.14 | 0.43±0.12 | 0.33 | 0.39±0.18 | 0.43±0.27 | 0.58 |
Soleus | 0.29±0.17 | 0.35±0.27 | 0.60 | 0.40±0.29 | 0.38±0.31 | 0.58 |
Tibialis anterior | 1.1±1.9 | 0.49±0.25 | 0.89 | 0.49±0.20 | 0.53±0.22 | 0.26 |
SLDI, Spastic Locomotor Disorder Index; SSRI, selective serotonin reuptake inhibitor; 5HT, serotonergic.